NCT01912638View on ClinicalTrials.gov

Trabeculectomy With Ologen Collagen Implant vs Trabeculectomy With Provisc in Steroid Induced Glaucoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Steroid Induced Glaucoma
Interventions
DEVICE

Ologen Collagen Matrix

Ologen is a porous collagen-glycosaminoglycan matrix that decrease early postoperative scarring after penetrating anti-glaucomatous surgery by randomized collagen deposition and microcyst formation. Implantation of Ologen Collagen Matrix in trabeculectomy was performed.

DRUG

Provisc

Provisc is an cohesive viscoelastic.

Trial Locations (1)

AZ1114

National Centre of Ophthalmology named after academician Zarifa Aliyeva, Baku

All Listed Sponsors
collaborator

Aeon Astron Europe B.V.

INDUSTRY

lead

National Centre of Ophthalmology named after academician Zarifa Aliyeva

OTHER_GOV

NCT01912638 - Trabeculectomy With Ologen Collagen Implant vs Trabeculectomy With Provisc in Steroid Induced Glaucoma | Biotech Hunter | Biotech Hunter